European biotechs: healthy growth
Date: 22.7.2008
The **European biotech industry** continued to show strong growth, according to an analysis of the auditing company **Ernst & Young** (E&Y). In terms of financing, the continent’s sector had **a very strong year**, raising a total of EUR 5.5bn in debt and equity capital. This is an increase of 18% from the EUR4.6bn raised in 2006. This was the largest-ever total for the European-industry, excluding the bubble year of 2000, and represents the fifth consecutive year in which capital has increased at double-digit rates.
"European Biotechnology Science & Industry News":[ http://www.eurobiotechnews.eu/service/current-issue/top-news/news//european-biotechs-healthy-growth.html?cHash=cb5cba3965]
